As more consumers turn to GLP-1 medications, the habits they accelerate, from smaller portions to more protein, nutrient density and gut health, are going mainstream.
In this webinar, Innova Market Insights will share key findings from their GLP-1 Report.
FoodChain ID will use this trend as a case study, showing how connected data and AI help R&D teams assess a change’s impact across formulation, regulatory, quality, supply chain and cost before committing, then reformulate at scale.
See how this integrated approach can drive better decisions for any consumer or regulatory change.





